Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Benekli

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|March 5, 2009
Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown originAli Osman Kaya, Ugur Coskun, Mustafa Unlu, et al.
Journal of Chemotherapy (Florence, Italy)|October 9, 2012
The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimensAli Osman Kaya, Ugur Coskun, Mahmut Gumus, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 20, 2018
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)Ersin Ozaslan, Metin Ozkan, Irfan Cicin, et al.
Journal of Chemotherapy (Florence, Italy)|October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2012
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Metin Ozkan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)Onur Esbah, Umut Demirci, Faysal Dane, et al.
Tumori|September 18, 2010
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancerAli Osman Kaya, Suleyman Buyukberber, Faysal Dane, et al.
Onkologie|December 5, 2012
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experienceBulent Cetin, Mustafa Benekli, Berna Oksuzoglu, et al.
Oncology Letters|October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experienceUmut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancerOnder Tonyali, Ugur Coskun, Nur Sener, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Asian Pacific Journal of Cancer Prevention : APJCP|March 5, 2009
Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown originAli Osman Kaya, Ugur Coskun, Mustafa Unlu, et al.
Journal of Chemotherapy (Florence, Italy)|October 9, 2012
The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimensAli Osman Kaya, Ugur Coskun, Mahmut Gumus, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 20, 2018
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)Ersin Ozaslan, Metin Ozkan, Irfan Cicin, et al.
Journal of Chemotherapy (Florence, Italy)|October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2012
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Metin Ozkan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)Onur Esbah, Umut Demirci, Faysal Dane, et al.
Tumori|September 18, 2010
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancerAli Osman Kaya, Suleyman Buyukberber, Faysal Dane, et al.
Onkologie|December 5, 2012
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experienceBulent Cetin, Mustafa Benekli, Berna Oksuzoglu, et al.
Oncology Letters|October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experienceUmut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancerOnder Tonyali, Ugur Coskun, Nur Sener, et al.
Pageof 13